CFGS
NVAX icon

Concourse Financial Group Securities’s Novavax NVAX Stock Holding History

Concourse Financial Group Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$8 – 1393
2024
Q4 		$8 Buy
+1
New +$10 ﹤0.01% 2237
2022
Q1 		– Sell
-25
Closed -$2.23K – 2351
2021
Q4 		$4K Hold
25
– – ﹤0.01% 2098
2021
Q3 		$5K Buy
+25
New +$5.51K ﹤0.01% 2073
2021
Q2 		– Sell
-10
Closed -$1.83K – 2413
2021
Q1 		$2K Buy
+10
New +$1.99K ﹤0.01% 2147
2020
Q3 		– Sell
-150
Closed -$18.3K – 2225
2020
Q2 		$13K Buy
+150
New +$5.74K ﹤0.01% 1429
2019
Q1 		– Sell
-425
Closed -$13.4K – 2363
2018
Q4 		$15K Buy
+425
New +$16.5K ﹤0.01% 1279

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Concourse Financial Group Securities's NVAX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Novavax (NVAX) in Q1 2025, closing a stake of 1 share — an estimated $8 sold.

Concourse Financial Group Securities first reported a position in NVAX in Q4 2018 and held it in 6 quarters. The position peaked at $15K in Q4 2018. 246 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1 Novavax share in Q1 2025, an estimated $8.
  • Concourse Financial Group Securities first reported a position in Novavax in Q4 2018 and held it in 6 quarters.
  • Concourse Financial Group Securities's Novavax position peaked at $15K in Q4 2018.
  • 246 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.